Skip to content

Kawasaki MATCH Trial

Kawasaki MATCH: A Clinical Decision Support Tool to Detect KD

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07291245
Acronym
MATCH
Enrollment
200
Registered
2025-12-18
Start date
2025-03-01
Completion date
2026-10-31
Last updated
2025-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kawasaki Disease

Keywords

Kawasaki Disease, Machine-learning, Artificial Intelligence (AI), Decision support, Point-of-care

Brief summary

Evaluating the impact of a machine-learning clinical decision support tool on provider practice when evaluating febrile patients with Kawasaki Disease (KD) and non-KD illnesses.

Detailed description

Following laboratory evaluation, providers will be randomized to treat patients according to usual practice/standard of care vs. receiving clinical decision support from the Kawasaki MATCH tool - a previously validated machine-learning clinical decision support tool to identify Kawasaki Disease. The study aim is to evaluate the accuracy of Kawasaki MATCH prospectively when used at the point of care, as well as how this tool impacts clinical decisions including additional evaluation and hospital admission.

Interventions

OTHERKawasaki MATCH

Providers access the Kawasaki MATCH decision support tool. Patient information is entered into the tool and a risk score is indicated to the provider. Kawasaki MATCH is a previously validated machine-learning decision support tool for the diagnosis of Kawasaki Disease. This tool utilizes patient age, 18 laboratory features, and 5 clinical features to formulate a risk score.

Sponsors

Gordon and Marilyn Macklin Foundation
CollaboratorUNKNOWN
Rady Children's Hospital, San Diego
CollaboratorOTHER
University of California, San Diego
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Days to 17 Years
Healthy volunteers
No

Inclusion criteria

* Measured or subjective fever for \>= 3 calendar days * One measured fever \>= 38.0 C (home or in ED) * One or more clinical feature of Kawasaki Disease including: * Rash * Conjunctival injection * Oropharyngeal changes * Extremity changes (erythema, edema, desquamation) * Cervical adenopathy (\>=1.5cm) * Infants \< 6 months of age with \>= 7 days of fever eligible even if none of the above clinical features * Requires IV/phlebotomy for clinical evaluation

Exclusion criteria

* Congenital or Acquired Immune function * Genetic disorders * Current systemic steroid, immunosuppression, or chemotherapy treatment (not including inhaled steroids)

Design outcomes

Primary

MeasureTime frameDescription
Time to Kawasaki Disease treatment (KD patients only)90 daysTime in days from initial ED evaluation to initial IVIG treatment in patients ultimately diagnosed with Kawasaki Disease

Secondary

MeasureTime frameDescription
Hospital Admission RateDay 1 (day of enrollment)Proportion of patients admitted to the hospital from the Emergency Department (ED). Admitted patients = 1 Discharged patients = 0
Kawasaki Disease consultation rateDay 1 (day of enrollment)Proportion of patients receiving Kawasaki service consultation
ED return visit7 daysReturn to Emergency Department
Kawasaki MATCH scoreDay 1 (day of enrollment)MATCH score determined by entering patient clinical and laboratory information into the Kawasaki MATCH algorithm. Algorithm output is a decimal between 0 and 1. Scores less than 0.4 will be deemed a prediction of not Kawasaki Disease while scores of 0.4 or higher will be deemed Kawasaki Disease
Provider assessment of KD likelihood - baselineDay 1 (day of enrollment)Visual analog scale of suspected likelihood of Kawasaki Disease. Scale between 0 (Definitely not Kawasaki Disease) and 100 (Definitely Kawasaki Disease) with higher values indicating higher provider suspicion for Kawasaki Disease. This outcome will be assessed on providers randomized to both study arms
Provider assessment of KD likelihood - after algorithmDay 1 (day of enrollment)Visual analog scale of suspected likelihood of Kawasaki Disease. Scale between 0 (Definitely not Kawasaki Disease) and 100 (Definitely Kawasaki Disease) with higher values indicating higher provider suspicion for Kawasaki Disease. This outcome only assessed for providers in the experimental arm.
Algorithm helpfulnessDay 1 (day of enrollment)Visual analog scale of the perceived helpfulness of the Kawasaki MATCH algorithm. Scale between 0 (Not helpful) and 100 (Extremely helpful) with higher values indicating increased helpfulness. This outcome only assessed for providers in the experimental arm.
Additional interventionsDay 1 (day of enrollment)Additional ED orders for laboratory/imaging studies or additional procedures after the time of randomization

Countries

United States

Contacts

Primary ContactMichael A Gardiner, MD
magardiner@health.ucsd.edu949-310-4808

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026